169 related articles for article (PubMed ID: 32630482)
1. Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia.
Rogier T; Samson M; Mourey G; Falvo N; Magy-Bertrand N; Ouandji S; Picque JB; Greigert H; Mausservey C; Imbach A; Ghesquière T; Voillat L; Caillot D; Deconinck E; Bonnotte B; Audia S
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32630482
[TBL] [Abstract][Full Text] [Related]
2. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.
Peng J; Ma SH; Liu J; Hou Y; Liu XM; Niu T; Xu RR; Guo CS; Wang XM; Cheng YF; Ni H; Hou M
J Thromb Haemost; 2014 Apr; 12(4):497-504. PubMed ID: 24517219
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between the expression of autoantibodies against platelet membrane glycoprotein and therapeutic effect in primary immune thrombocytopenia].
Liu XF; Xue F; Zhang L; Zhou XL; Liu YZ; Liu W; Chen YF; Huang YT; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):610-3. PubMed ID: 23906456
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia.
Zheng SS; Ahmadi Z; Leung HHL; Wong R; Yan F; Perdomo JS; Chong BH
Haematologica; 2022 Sep; 107(9):2195-2205. PubMed ID: 35199503
[TBL] [Abstract][Full Text] [Related]
5. Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients.
Ding B; Liu L; Li M; Song X; Zhang Y; Xia A; Liu J; Zhou H
Platelets; 2023 Dec; 34(1):2258988. PubMed ID: 37722393
[TBL] [Abstract][Full Text] [Related]
6. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies.
Webster ML; Sayeh E; Crow M; Chen P; Nieswandt B; Freedman J; Ni H
Blood; 2006 Aug; 108(3):943-6. PubMed ID: 16861348
[TBL] [Abstract][Full Text] [Related]
7. The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with immune thrombocytopenia.
Go RS; Johnston KL; Bruden KC
Haematologica; 2007 Feb; 92(2):283-4. PubMed ID: 17296593
[TBL] [Abstract][Full Text] [Related]
8. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia.
Li J; van der Wal DE; Zhu G; Xu M; Yougbare I; Ma L; Vadasz B; Carrim N; Grozovsky R; Ruan M; Zhu L; Zeng Q; Tao L; Zhai ZM; Peng J; Hou M; Leytin V; Freedman J; Hoffmeister KM; Ni H
Nat Commun; 2015 Jul; 6():7737. PubMed ID: 26185093
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Br J Haematol; 1997 Jul; 98(1):64-7. PubMed ID: 9233565
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous immunoglobulin on inhibition of fibrinogen binding to platelets by sera from patients with immune thrombocytopenia.
Kamiyama M; Yoshimura Y; Chen K; Arkel YS
Am J Hematol; 1993 Oct; 44(2):77-84. PubMed ID: 8266923
[TBL] [Abstract][Full Text] [Related]
11. Platelet-specific antibodies and differences in their expression in childhood immune thrombocytopenic purpura predicts clinical progression.
Fu L; Ma J; Cheng Z; Gu H; Ma J; Wu R
Pediatr Investig; 2018 Dec; 2(4):230-235. PubMed ID: 32851271
[TBL] [Abstract][Full Text] [Related]
12. Fc-independent phagocytosis: implications for IVIG and other therapies in immune-mediated thrombocytopenia.
Li J; van der Wal DE; Zhu L; Vadasz B; Simpson EK; Li C; Webster ML; Zhu G; Lang S; Chen P; Zeng Q; Ni H
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):50-8. PubMed ID: 23082940
[TBL] [Abstract][Full Text] [Related]
13. Recognition of the human antibody-mediated platelet destruction in adult ITP patients by C-reactive protein.
Pan JQ; Wang W; Wang ML; Li XY; Wang JH; Zhao WW; Tian YY; Dong XS; Jiang YF
Int J Clin Exp Pathol; 2017; 10(10):10176-10185. PubMed ID: 31966351
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia.
Huang CE; Chen YY; Chang JJ; Wu YY; Chen WM; Wang YH; Chen MC; Lu CH; Shi CS; Chen CC
Mediterr J Hematol Infect Dis; 2023; 15(1):e2023030. PubMed ID: 37180208
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and epitopes.
McMillan R
J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S57-61. PubMed ID: 14668642
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia.
Lipp E; von Felten A; Sax H; Müller D; Berchtold P
Eur J Haematol; 1998 May; 60(5):283-8. PubMed ID: 9654157
[TBL] [Abstract][Full Text] [Related]
17. Fc-independent phagocytosis: implications for intravenous IgG therapy in immune thrombocytopenia.
Webster ML; Zhu G; Li Y; Ni H
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):278-82. PubMed ID: 19075638
[TBL] [Abstract][Full Text] [Related]
18. Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia.
Tao L; Zeng Q; Li J; Xu M; Wang J; Pan Y; Wang H; Tao Q; Chen Y; Peng J; Hou M; Jansen AJ; Ni H; Zhai Z
J Hematol Oncol; 2017 Feb; 10(1):46. PubMed ID: 28179000
[TBL] [Abstract][Full Text] [Related]
19. Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.
Audia S; Mahévas M; Nivet M; Ouandji S; Ciudad M; Bonnotte B
Hemasphere; 2021 Jun; 5(6):e574. PubMed ID: 34095758
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against platelet GPIb/IX, GPIIb/IIIa, and other platelet antigens in chronic idiopathic thrombocytopenic purpura.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Eur J Haematol; 1995 Nov; 55(5):307-14. PubMed ID: 7493677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
